Abstract: Aims: To evaluate the relationships between F352V polymorphism of Klotho gene, bone mineral density (BMD), and intima-media thickness (IMT) of the common carotid artery in postmenopausal women. Methods: Spine and hip BMD was assessed by dual energy X-ray absorptiometry (DXA), and IMT was measured by ultrasonography in 184 postmenopausal women. The genotyping of the Klotho gene was performed by polymerase chain reaction-restriction fragment length polymorphism. Results: Genotype frequencies were 81.5% for the homozygous wild type FF and 18.5% for the combined FV and VV genotypes. There were no significant differences in BMD at any site of measurement and mean carotid artery IMT across Klotho genotypes. In regression analysis, femoral neck BMD, but not total hip or lumbar spine BMD, was negatively associated with mean carotid IMT (p = 0.04). Patients with low femoral neck BMD had a significantly higher prevalence of carotid artery plaques as compared to those with normal BMD (p = 0.01). Conclusion: The F352V polymorphism in the Klotho gene does not have a significant influence on bone mass and carotid atherosclerosis in postmenopausal women. Femoral neck BMD is associated with mean carotid IMT, suggesting that low bone mass may identify postmenopausal women at risk of atherosclerotic CVD.
Introduction
Osteoporosis and cardiovascular diseases (CVD) are multifactorial diseases that often coexist in postmenopausal women. In epidemiologic studies, low bone mineral density (BMD) has been related to increased cardiovascular morbidity and mortality and to markers of subclinical atherosclerosis [1] [2] [3] . A recent study suggests the implication of genetic factors in the association between CVD and osteoporosis [4] . Also, several studies have reported that polymorphisms of a number of candidate genes may influence both osteoporosis and CVD [5] [6] [7] [8] . Kuro-o et al. [9] have shown that a defect in Klotho gene expression in mice results in a syndrome resembling human aging, including vascular calcification, osteoporosis, infertility, emphysema, skin atrophy, cognitive impairment, and a short lifespan. Several single nucleotide polymorphisms (SNPs) in human Klotho gene and association with a variety of phenotypes have been reported. A functional vari-ant of Klotho gene, termed KL-VS, has been identified. This variant, present in approximately 16% of Caucasians, is characterized by six SNPs in the exon 2 and its flanking sequence in complete linkage disequilibrium. Two of these SNPs -F352V (rs9536314) and C370S (rs9527025) -result in amino acid substitutions which alter Klotho metabolism, and thereafter may have important functional consequences. A single variant, F352V polymorphism, which caused a phenylalanineto-valine substitution at amino acid position 352, can be used to define the functional haplotype of Klotho gene (KL-VS refers to the presence of the variant type V alleles of this SNP). Arking et al. [10] demonstrated that individuals with heterozygous allele phenotype FV (the wild-type allele is termed F, and the rare, mutant allele, V) have the lowest mortality, whereas the homozygous status for the KL-VS allele (VV genotype) was associated with decreased longevity. Recent studies have associated KL-VS status with longevity [11] , occult coronary artery disease [12] , ischemic stroke [11, 13] , highdensity lipoprotein (HDL) cholesterol levels [11] , systolic blood pressure [11, 14] metabolic syndrome [15] and BMD [16] . This suggests a possible contribution of the Klotho gene to the pathophysiology of both atherosclerosis and osteoporosis.
An increased carotid intima-media thickness (IMT) has been associated with coronary artery disease, stroke, and cardiovascular mortality in the general population. Therefore, the measurement of mean IMT is increasingly used as a surrogate marker for atherosclerosis [17] . An inverse relationship bone mass and various measures of subclinical atherosclerosis, including IMT has been reported in many studies [18] [19] [20] [21] . However, the nature of the relationship between these two entities remains a matter for controversy.
The aim of this cross-sectional study was to evaluate the relationships between F352V polymorphism in the Klotho gene, BMD, and IMT of the common carotid artery in a cohort of postmenopausal Romanian women.
Patients and methods

Patients
In this cross-sectional study, 184 postmenopausal Romanian women, referred for BMD measurement at the Rheumatology Department "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, between September 2009 and February 2010, were consecutively enrolled. Women were eligible if menopause had occurred at least one year prior to their visit. We excluded subjects with any condition or treatment that might have affected bone metabolism (malabsorption, chronic renal and liver diseases, thyroid diseases, rheumatoid arthritis and other inflammatory rheumatic diseases, alcoholism, corticosteroids, anticonvulsants). No participant was receiving therapy for osteoporosis.
Written informed consent for participation was obtained from each subject prior to enrolment and the study was approved by the University Ethics Committee.
Clinical and laboratory assessments
Data collected from the personal interview included age, age at menopause, time elapsed since menopause, and medical history, including the presence of hypertension, diabetes mellitus, hyperlipidemia, current smoking, myocardial infarction, angina pectoris, stroke, and prescribed medications. All participants underwent a complete medical examination, including weight and height measurements (using an automatic scale), calculation of body mass index (BMI = weight/height 2 , kg/m 2 ), and measurement of waist circumference. Hypertension was defined as systolic blood pressure >140 mmHg and diastolic blood pressure >90 mmHg or use of antihypertensive medication [22] . Diabetes mellitus was defined as fasting glucose ≥126 mg/dl or use of anti-diabetic agents [23] . Hyperlipidemia was defined as total-cholesterol ≥220 mg/dl, triglyceride ≥50 mg/dl, or undergoing treatment with lipid-lowering medication to reduce blood lipids [24] .
Blood samples were collected after an overnight fast. Serum total cholesterol, triglyceride and glucose were measured using commercially available kits on Cobas Mira Plus Analyzer (Roche Diagnostic Systems, Inc, Branchburg, NJ).
Ultrasonographic measurements of carotid IMT and plaques
The carotid artery wall thickness was measured bilaterally using an Aloka Prosound alpha 10, Tokyo, Japan machine with a 7.5 to 13 MHz linear probe by the same examiner. The protocol involved longitudinal scanning of the common carotid arteries on the far-wall (posterior wall) at 10, 15, and 20 mm proximally to the bifurcation. We calculated the IMT by averaging the thickness of the three selected sites at the far-wall for both the right and left distal common carotid artery. For each subject, the final common carotid IMT was determined as the average of far-wall measurements of both left and right arteries. In patients with carotid atherosclerotic plaques, IMT measurements were done outside the plaque's edges [25] . To determine the intra-observer variability of IMT measurement, 15 volunteers were examined in two different occasions over a one week period. The coefficient of variation was 10%.
Atherosclerotic plaque was recorded as present or absent on the common, internal and external carotid artery walls. A plaque was defined as a focal widening of the carotid wall relative to adjacent segments with protrusion into the vessel lumen.
Genotyping of the Klotho F352V polymorphism
Genotyping of the Klotho F352V polymorphism was performed by PCR-RFLP (polymerase chain reaction -restriction fragment length polymorphism), essentially as previously described by Wolf et al. [26] . The genomic DNA was obtained from peripheral blood leucocytes, using a commercially available procedure (Wizard Genomic DNA Purification Kit, Promega, USA). An 164-bp amplicon was obtained by PCR, using the following primers: 5'-GAAGAATGACCGACCACAG-3' and 5'-AT-GAACTTTTTCTCAGATTCTTTAA-3', under the following conditions: initial denaturation 10 min at 95ºC, followed by 35 cycles, each consisting in denaturation 30s at 95ºC , annealing 1 min at 50ºC and elongation 30s at 72ºC, and final elongation 7 min at 72ºC. The amplicon was digested overnight at 37ºC with the restriction enzyme DraI (Fermentas MBI, Vilnius, Lithuania). The digestion products were resolved in 3% high resolution agarose gel electrophoresis (MetaPhor, Lonza, Switzerland), stained with ethidium bromide. The common allele (F352 allele) was cut into 2 fragments, of 138 and 26-bp, whereas the variant allele (V352 allele) was resistant to the digestion with DraI enzyme.
BMD assessments
BMD of the lumbar spine (L2-L4), femoral neck, and total hip was measured by dual energy X-ray absorptiometry (DXA) using a Lunar Prodigy Advance (GE Healthcare, USA). All BMD measurements were made with the same densitometer at a single centre. Results were expressed as BMD in g/cm 2 , and also as T-score (standard deviation from peak adult BMD) and Z-score (standard deviation from age-matched BMD). The spine phantom precision error calculated as coefficient of variation was 0.7% for the entire period during which measurements were obtained. All measurements were made by two operators. The inter-and intra-operator coefficients of variation were less than 1.3%. According to the WHO criteria, osteopenia was defined as T-score between -1 and -2.5 SD and osteoporosis as a T-score below -2.5 SD [27] .
Statistical analysis
The statistical analysis was carried out using the program SPSS version 16 
Results
Comparison of patients according to Klotho
F352V genotypes
We studied a total of 184 postmenopausal women with a mean age 64.5 (SD 9.4) years. Atherosclerotic plaques were present at one or more of the measured sites in 54% of the subjects. CVD history was positive in 17 (9.2%) patients: 12 (6.5%) had stroke; 2 (1.1%) myocardial infarction; and 3 (1.6%) angina pectoris. Among the patients, 28% had diabetes; 66.3%, hypertension; 61.1%, hyperlipidemia; and 5.4% were current smokers.
Of the 184 postmenopausal women, 150 [81.5% (95% CI 75.1-86.9)] were homozygous for the wild type FF allele, 33 [17.9% (95% CI 12.7-24.3)] were heterozygous (FV allele), and 1 [0.5% (95% CI 0.0-3.0)] was homozygous for the variant type VV allele. The genotype frequencies were consistent with the HardyWeinberg equilibrium (χ2 = 0.32; p = 0.57). Given the low frequency of the VV genotype (<1%), FV and VV genotypes were combined in subsequent analysis. The clinical, biochemical, ultrasonographic, and osteodensitometric variables did not significantly differ between groups of genotypes (Table 1 ; all p >0.05).
According to the WHO classification for the lumbar spine BMD, 23% (95% CI 17.1-29.7) postmenopausal women were osteoporotic and 36.1% (95% CI 29.1-43.5) were osteopenic. At the femoral neck and total hip, 13% (95% CI 8.5-18.8), and 10.9% (95% CI 6.8-16.3) respectively, were osteoporotic. In addition, 51.6% (95% CI 44.2-59.0) patients were osteopenic at the femoral neck and 27.7% (95% CI 21.4-34.8) at the total hip. There was no difference between the frequency of osteopenia and/or osteoporosis at the lumbar spine and femoral neck between postmenopausal women with at least one V allele as compared to women with no V allele (all p >0.05). We did find, however, an association between F352V genotypes and total hip bone loss, the women with V allele (genotype FV + VV) having more frequently total hip osteopenia than patients with FF genotype (42.4% vs. 24.6%, p = 0.04).
Comparison of patients according to bone status
We investigated a potential association between carotid artery parameters and other risk factors for cardiovascular diseases with BMD at different sites. Comparison of clinical, laboratory and ultrasound variables between postmenopausal women with osteoporosis, osteopenia, and normal BMD at lumbar spine and femoral neck, are summarized in Table 2 and Table 3 , respectively.
There was no statistically significant difference in the mean values of IMT across the spine bone status (p = 0.07, Table 2 ). Mean IMT was significantly higher in patients with femoral neck osteoporosis as compared with patients with femoral neck osteopenia (p = 0.03), but not with normal femoral neck BMD (p = 0.08). In patients with total hip osteoporosis, mean IMT was 1.267 [1.25] 2 ) (p = 0.03, p = 0.02, respectively). There was no statistically significant trend in the proportion of atherosclerotic plaques across the spine and total hip bone status groups (all p >0.05). Patients with low BMD (osteopenia or osteoporosis) at the femoral neck have significantly higher prevalence of carotid artery plaques as compared with those with normal BMD (both p <0.01, Table 3 ).
Association between BMD, mean IMT, and Klotho F352V genotypes
BMD was directly associated with BMI and waist circumference at all measured bone sites (r value ranging from 0.23 to 0.38; all p <0.01). There was a significant negative correlation between age and BMD at the femoral neck and total hip (r = -0.34, p <0.0001 and r = -0.23, p = 0.002, respectively). No correlation was observed between the lumbar spine BMD and age (p > 0.05). Furthermore, time since menopause correlated with the femoral neck and total hip BMD (r = -0.39, and r = -0.26, respectively; both p < 0.0001), but not with lumbar spine BMD (p > 0.05). Lumbar spine BMD correlated significantly with triglyceride and glucose levels (<rho> = 0.18, p = 0.02 and <rho> = 0.23, p < 0.001, respectively). A positive correlation was also observed between glycemia and the total hip BMD (<rho> = 0.18, p = 0.02). We found no correlation between mean IMT and BMD at the femoral neck and total hip (all p >0.05). A significant positive correlation was observed between mean IMT and mean BMD Z-score at the lumbar spine (<rho> = 0.19, p = 0.008). Mean IMT correlated positively with cholesterol levels (<rho> = 0.23, p = 0.002), but not with triglyceride or glucose levels (both p > 0.05).
Regression analysis was performed to identify the most important predictors of BMD at different sites of measurement. The eligible independent variables included were: age, age at menopause, time since menopause, BMI, fasting glucose, total cholesterol, triglycerides, mean IMT, and Klotho genotype (FF vs FV+VV). Because the variables age at menopause, fasting glucose, triglycerides, and mean IMT are not normally distributed and the Klotho genotype is a qualitative variable, we used the regression model for ordinal categorical data (Table 4) . In this regression model, age, time since menopause, and BMI were independently associated with BMD at all sites. Age at menopause correlated with lumbar spine and total hip BMD, but not with femoral neck BMD. At all sites except femoral neck we detected significant effects (p <0.05, Table 4 ) of the glucose, cholesterol and triglycerides levels on BMD, and this interaction effect was strongest on spine BMD. Femoral neck, but not total hip or lum- 
Discussion
The results of our study indicated that F352V polymorphism of the Klotho gene did not have a significant effect on BMD and common carotid IMT measurements in a cohort of postmenopausal women. Neither mean values of BMD at any site of measurement nor mean values of carotid IMT differed significantly among the two genotype groups. We did observe a weak genotyperelated difference at the total hip, where postmenopausal women bearing at least one V allele (genotype FV + VV) had more frequently osteopenia than those with the FF genotype. However, the results of the regression analysis showed no contribution of the Klotho F352V polymorphism to BMD variance. This indicates that the increased prevalence of total hip osteopenia in patients with the minor allele V may be a spurious finding. Similar to our study, Arking et al. [10] showed that approximately 1% of elderly from Bohemian Czech and Caucasian Baltimore populations express the variant homozygous phenotype VV. A higher frequency (2.1%) was found in Baltimore African-Americans; however, the difference was not statistically significant. The authors concluded that, "large differences in allele frequencies were not observed between ethnically and or geographically diverse populations for a given age group," However, our patients were younger than in the aforementioned study. In a study performed on a large Italian population sample, Invidia et al. [28] reported a higher frequency of carrier of VV genotype (2.6%) in an age group similar to that of our patients group. We believe that the lack of evidence of F352 polymorphism effect on BMD and IMT measurements observed in our study is much more likely a result of the small sample size, rather than from differences in the allele frequency.
Based on the finding that Klotho-deficient mice exhibited multiple aging phenotypes, including osteoporosis [9] , several researchers investigated the possible association of Klotho gene polymorphisms with BMD, but their studies yielded conflicting results. In contrast to our study, Riancho et al. [29] showed that the common allelic variant of F352V Klotho (FF genotype) was associated with BMD in postmenopausal Spanish women, but not with the risk of osteoporotic fractures. Nevertheless, those authors failed to show an association between the functional variant of Klotho and BMD in premenopausal women. They suggested that the Klotho gene may be related to menopausal bone loss, rather than to the peak bone mass achieved in young adulthood. Another study by the same group [16] showed that the functional variant of Klotho constituted one of the genetic factors influencing BMD in male adults. In this study, FV/VV genotype of the Klotho gene was associated to bone mass in young and middle-aged men but not in older men, suggesting a link between the Klotho gene and peak bone mass in males. The mechanisms explaining sex-related differences have not been elucidated as yet. Also, the mechanism whereby the Klotho gene polymorphisms affect bone density is still unclear.
Kawano et al. [30] showed that two other SNPs of the Klotho gene, G-398A and C1818T, were significantly associated with BMD in aged postmenopausal women of European and Japanese origin. However, the same study failed to show significant associations between the functional variant of Klotho and BMD in any subpopulation. Other studies also recorded a relationship between different Klotho gene polymorphisms and bone mass in postmenopausal women of Asian origin [31, 32] . In a recent study, Mullin et al. [33] reported that Klotho gene polymorphisms were associated with osteocalcin levels, but not with BMD in aged postmenopausal Caucasian women. These divergent results are probably explained by differences in the race and ethnicity of the studied populations,and by different modalities used for BMD measurements. The pathogenesis of osteoporosis is mediated by an interaction between several genes and environmental factors. Existing evidence suggests that genetic contribution to the variance in BMD is about 60% to 85% [34] . Over the past decade, several reviews on the genetics of osteoporosis have tried to summarize the most representative osteoporosis association studies [35] [36] [37] . Examples of candidate genes involved in bone loss pathogenesis include vitamin D receptor (VDR), collagen type I-α1 (COL1A1), estrogen receptor (ESR1), transforming growth factor-β1 (TGFB1), lipoprotein receptor-related protein 5 (LRP5), and sclerostin (SOST) [36] . Most studies have found that the contribution of each candidate gene to this complex polygenic trait is rather small. In line with these findings, two recent studies have shown that the contribution of Klotho alleles is about 1.5%-4% of the BMD variance [16, 29] . It appears that other candidate gene in conjunction with environmental factors may obscure the effect of Klotho gene polymorphisms on bone mass in some populations [33] .
Traditionally, osteoporosis and CVD were seen as independent age-related diseases [38, 39] . Recent studies have pointed to several possible links between these two diseases that cannot be explained only by the aging process. Epidemiologic studies have demonstrated that both diseases share common risk factors including menopause, hypertension, diabetes mellitus, dyslipidemia, smoking, and low level of physical activity [40] . Moreover, various common pathogenetic pathways have been identified, including estrogen deficiency, similarities in the mechanisms of vascular calcification and bone mineralization, chronic low-grade inflammation and oxidative stress, hyperhomocysteinemia, and vitamin D and K abnormalities [1, 41] .
In our study, 54% of postmenopausal women had atherosclerotic plaques present in the carotid artery. Significantly more patients with femoral neck low bone mass (osteopenia or osteoporosis) had atherosclerotic plaques. We also found that the mean value of carotid IMT was significantly increased in patients with low BMD at the proximal femur (femoral neck and total hip). It is possible that these results were age related, as there was a significant difference in women with osteoporosis and normal BMD at the femoral neck and total hip.
In univariate analysis, we found no correlation between femoral neck or total hip BMD and common carotid IMT. In contrast, increased IMT was correlated with higher BMD Z scores at the lumbar spine BMD. However, it is known that DXA is affected by the presence of degenerative osteoarthritic changes or aortic calcification, which leads to a falsely increased BMD at the spine [41] . In multivariate analysis, we identified a weak inverse association between mean IMT and femoral neck BMD.
Recent literature has documented a relationship between bone mass and various measures of subclinical atherosclerosis [3] . In a cross-sectional analysis of 30 postmenopausal women, Uyama et al. [43] showed that total BMD negatively correlated with plaque score, whereas lumbar spine BMD did not. Also, in the study of Yamada et al. [32] , there was a significant association of femoral artery IMT with calcaneal ultrasonometry parameters, but not with spine BMD measured by DXA. A recent cross-sectional study reported that only hip BMD was negatively associated with carotid IMT, but not with femoral artery IMT [44] . In contrast, Sumino H et al. [21] observed that lumbar spine BMD was negatively associated with carotid IMT. In a population-based study, it was demonstrated that decreased BMD was associated with increased IMT in older, but not younger, Mexican American men and women, independent of CVD risk factors [45] . Recently, Kim SH et al. [19] showed that osteoporotic vertebral fractures were associated with an increased risk of echogenic atherosclerotic plaques in postmenopausal women with low bone mass. Other studies failed to observe an association between BMD and subclinical atherosclerosis [38, 39, 46] .
The main shortcomings of our study were the small sample size that limited our power to detect small effects and that we tested only one SNP in the candidate gene. Recruitment of our patients was not community based: participants were selected from patients referred by different specialists for BMD testing, which explains the high prevalence of osteoporosis in our patients. Thus, our results cannot be generalized to the population at large or other ethnicities. Also, we did not exclude from the analysis patients with a previous atherosclerotic cardiovascular event at baseline, but the proportion of such patients was small (less than 10%). Another limitation of our analysis was its cross-sectional nature, which did not allow the evaluation of a causal relation between osteoporosis and CVD. Further prospective studies based on large populations of different ethnicity are necessary to elucidate the role of Klotho gene polymorphisms in the susceptibility to osteoporosis and atherosclerosis, and the association between these two entities as well. To conclude, the F352V Klotho gene polymorphism was not found to be associated with BMD and common ca-rotid IMT in postmenopausal women, suggesting that Klotho gene variants might not significantly influence atherosclerotic risk and bone loss in this population. Our results, which show an inverse relationship between femoral neck BMD and IMT in postmenopausal women, support the hypothesis that common etiological factors are involved in osteoporosis and atherosclerosis. In clinical practice, patients with osteoporosis should be evaluated for the risk of atherosclerotic CVD.
